More High Blood Pressure Drugs Recalled Due to Potential Carcinogens, FDA Says

N-nitroso prazosin, a type of nitrosamine, is above the FDA’s acceptable limits, the agency says.

The U.S. Food and Drug Administration building in White Oak, Md., on June 5, 2023.Madalina Vasiliu/The Epoch Times

The Food and Drug Administration confirmed in several notices that a recall of a type of high blood pressure medication has been expanded due to the presence of a potentially carcinogenic substance.

In three notices issued this week, the FDA confirmed that 7,198 cartons of prazosin hydrochloride are being recalled nationwide by Ohio-based Amerisource Health Services and classified the recall as Class II.